Lista de obras -

3',5'Di-O-trityluridine inhibits in vitro flavivirus replication

artículo científico publicado en 2013

3′,5′di-O-Trityluridine Inhibits Flavivirus (Dengue and Yellow Fever Virus) Replication and Targets the Viral RNA Dependent RNA Polymerase

article by Tine De Burghgraeve et al published May 2011 in Antiviral Research

A Derivate of the Antibiotic Doxorubicin Inhibits Dengue and Yellow Fever Virus Replication In Vitro

article by Suzanne Kaptein et al published May 2008 in Antiviral Research

A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitro

artículo científico publicado en 2010

Aeromedical Transfer of Patients with Viral Hemorrhagic Fever

artículo científico publicado en 2019

An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro

artículo científico publicado en 2012

An improved endothelial barrier model to investigate dengue haemorrhagic fever

artículo científico publicado en 2002

Analysis of an Ebola virus disease survivor whose host and viral markers were predictive of death indicates the effectiveness of medical countermeasures and supportive care

artículo científico publicado en 2021

Antibody therapeutics for Ebola virus disease

artículo científico publicado en 2016

Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study

artículo científico publicado en 2021

Clinical and virological study of dengue cases and the members of their households: the multinational DENFRAME Project

artículo científico publicado en 2012

Clinical features and management of human monkeypox: a retrospective observational study in the UK

artículo científico publicado en 2022

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study

scientific article published in 2021

Dengue Virus Replicon Expressing the Nonstructural Proteins Suffices To Enhance Membrane Expression of HLA Class I and Inhibit Lysis by Human NK Cells

artículo científico publicado en 2008

Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression

artículo científico publicado en 2005

Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study

artículo científico publicado en 2021

Diagnostics in Ebola Virus Disease in Resource-Rich and Resource-Limited Settings

artículo científico publicado en 2016

Ebola Virus Shedding and Transmission: Review of Current Evidence.

artículo científico publicado en 2016

Ebola virus disease and critical illness

artículo científico publicado en 2016

Ebola virus disease: an update on post-exposure prophylaxis

artículo científico publicado en 2017

Evidence-based guidelines for supportive care of patients with Ebola virus disease

artículo científico publicado en 2017

Febrile illness in healthcare workers caring for Ebola virus disease patients in a high-resource setting

artículo científico publicado en 2017

Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication

artículo científico publicado en 2013

Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study

artículo científico publicado en 2022

Late Ebola virus relapse causing meningoencephalitis: a case report

artículo científico publicado en 2016

Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial

More Challenges From Ebola: Infection of the Central Nervous System

artículo científico publicado en 2016

New filovirus disease classification and nomenclature

article

Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study

artículo científico publicado en 2021

Post-exposure prophylaxis against Ebola virus disease with experimental antiviral agents: a case-series of health-care workers

artículo científico publicado en 2015

Provision of care for Ebola

artículo científico publicado en 2014

Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK

artículo científico publicado en 2021

SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

artículo científico publicado en 2023

Terminal decontamination of the Royal Free London's high-level isolation unit after a case of Ebola virus disease using hydrogen peroxide vapor

artículo científico publicado en 2015

Tetracycline-inducible packaging cell line for production of flavivirus replicon particles

artículo científico publicado en 2004

Thromboelastography in the Management of Coagulopathy Associated With Ebola Virus Disease

artículo científico publicado en 2015

Two cases of monkeypox imported to the United Kingdom, September 2018

artículo científico publicado en 2018

Lista de obras de

3',5'Di-O-trityluridine inhibits in vitro flavivirus replication

3′,5′di-O-Trityluridine Inhibits Flavivirus (Dengue and Yellow Fever Virus) Replication and Targets the Viral RNA Dependent RNA Polymerase

A Derivate of the Antibiotic Doxorubicin Inhibits Dengue and Yellow Fever Virus Replication In Vitro

A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitro

Aeromedical Transfer of Patients with Viral Hemorrhagic Fever

An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro

An improved endothelial barrier model to investigate dengue haemorrhagic fever

Analysis of an Ebola virus disease survivor whose host and viral markers were predictive of death indicates the effectiveness of medical countermeasures and supportive care

Antibody therapeutics for Ebola virus disease

Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study

Clinical and virological study of dengue cases and the members of their households: the multinational DENFRAME Project

Clinical features and management of human monkeypox: a retrospective observational study in the UK

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study

Dengue Virus Replicon Expressing the Nonstructural Proteins Suffices To Enhance Membrane Expression of HLA Class I and Inhibit Lysis by Human NK Cells

Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression

Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study

Diagnostics in Ebola Virus Disease in Resource-Rich and Resource-Limited Settings

Ebola Virus Shedding and Transmission: Review of Current Evidence.

Ebola virus disease and critical illness

Ebola virus disease: an update on post-exposure prophylaxis

Evidence-based guidelines for supportive care of patients with Ebola virus disease

Febrile illness in healthcare workers caring for Ebola virus disease patients in a high-resource setting

Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication

Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study

Late Ebola virus relapse causing meningoencephalitis: a case report

Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial

More Challenges From Ebola: Infection of the Central Nervous System

New filovirus disease classification and nomenclature

Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study

Post-exposure prophylaxis against Ebola virus disease with experimental antiviral agents: a case-series of health-care workers

Provision of care for Ebola

Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK

SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

Terminal decontamination of the Royal Free London's high-level isolation unit after a case of Ebola virus disease using hydrogen peroxide vapor

Tetracycline-inducible packaging cell line for production of flavivirus replicon particles

Thromboelastography in the Management of Coagulopathy Associated With Ebola Virus Disease

Two cases of monkeypox imported to the United Kingdom, September 2018